within Pharmacolibrary.Drugs.V_Various.V08A_XRayContrastMediaIodinated.V08AA08_IocarmicAcid;

model IocarmicAcid
  extends Pharmacolibrary.Drugs.ATC.V.V08AA08
  // parameters inherited from base class, duplicate, uncomment and change if necesarry
  /*
  
    weight         = 70,
    F              = 1,
    Cl             = 1.4e-06,
    adminDuration  = 600,
    adminMass      = 300 / 1000000,
    adminCount     = 1,
    Vd             = 0.00025,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01  
  */
  ;

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>IocarmicAcid</td></tr><tr><td>ATC code:</td><td>V08AA08</td></tr><td>route:</td><td>intravenous</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>300</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>0.25</td><td>L</td></tr>
    <tr><td>clearance:</td><td>1.2</td><td>mL/min/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Iocarmic acid is an iodinated, water-soluble radiographic contrast agent that was previously used in diagnostic imaging procedures such as urography and angiography. It is no longer widely used today due to the development of safer, less toxic contrast agents.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for typical adult subjects, as no primary clinical pharmacokinetic studies or data are available in literature.</p><h4>References</h4><ol></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end IocarmicAcid;
